More information about the deal is available on www.premierbiopharmaleader.com and www.Allergan.com. I’ve also attached a first set of FAQs for your review.
This is a new chapter in our story, not an end
By combining forces with Pfizer, we will continue our bold path to change lives for the better. At the same time, combining with Pfizer enables us to join on their path of transformation which began in 2010 when Ian Read became the CEO. Ian has led changes at Pfizer that many didn’t think possible for a company so large -- buying attractive companies and products, divesting successful legacy businesses, opening up their research labs to external innovation and setting up strong business units that run autonomously. He did this while instilling a new ‘OWN IT’ culture that is about taking risks and achieving results.